Private Equity

Sarah Pringle

Highlander's Bettera sold to Catalent for $1bn, Linden makes almost 4.5x its money on recent Flexan sale

Highlander sells Bettera to Catalent while Linden generates almost 4.5x return on Flexan,

3 min read · 30 August 2021

Deals

Highlander Partners sells Bettera to Catalent

Highlander formed the manufacturer of gummy vitamin, soft chews and lozenges through a series of four acquisitions beginning in 2017.

3 min read · 30 August 2021

Deals

Linden makes nearly 4.5x its money on Flexan

Under Linden's six-year-plus hold, the CDMO grew its capabilities and added facilities with the acquisition of two Salt Lake City-based companies while recruiting several seasoned executives to the C-suite.

3 min read · 27 August 2021

Deals

Ontario Teachers' buys majority stake in Acorn Health

MBF Healthcare Partners, which has supported the ABA therapy platform since its 2018 founding, will exit its investment with the deal.

3 min read · 27 August 2021

GTCR values Global Claims Services at roughly $500m, ACON Investments' BioMatrix explores sale

GTCR acquires Global Claims Services while ACON-backed BioMatrix hits the market.

2 min read · 27 August 2021

Deals

Vesey Street Capital Partners recapitalizes Safecor Health

The private equity firm plans to enable the healthcare company's next phase of growth, including via add-on acquisitions.

3 min read · 27 August 2021

MBF Healthcare Partners sells Acorn Health to Ontario Teachers'

Under Coral Gables, Florida-based MBF, the autism services company has grown its network to 51 clinics across seven states.

2 min read · 27 August 2021

Deals

ACON Investments' BioMatrix is up for sale

The national provider of specialty pharmacy and home infusion services expects to field first-round bids in mid-September.

3 min read · 26 August 2021

Hildred-backed Crown Laboratories buys StriVectin from L Catterton

Upon completion of the transaction, StriVectin's products will become part of Crown's new Premium Skincare Division and will operate as a wholly owned subsidiary of Crown Laboratories.

6 min read · 26 August 2021

Deals

Halifax-backed PromptCare goes to Waud in $400m-plus deal

The Chicago PE shop is buying the provider of complex respiratory and infusion-therapy services via an initiative with former Onco360 CEO Paul Jardina, with a deal poised to close imminently.

3 min read · 25 August 2021

Showing 201 to 210 of 1,434 results
1…2022…144